In November 2025, DeSci’s market cap eclipses $702 million, up 25% quarter-over-quarter per CoinGecko, as AI integrations tokenize biotech IP into NFTs for fractional ownership and funding, injecting $150 million in TVL amid DeFi’s $289.9 billion stability, according to DefiLlama. This surge accelerates innovations in health, with ecosystems like Molecule’s Web3 marketplace minting IP-NFTs that blend legal rights with on-chain governance, yielding 18-25% APY for backers. Volatility persists—Bitcoin’s 15% swings rerouted $45 million into DeSci—but AI agents now automate 40% of funding, compressing timelines from years to months. Here’s the top 10 DeSci projects by market cap, ranked for their IP tokenization prowess.
1. Bio Protocol (BIO): $304 million cap, BIO powers BioDAOs for tokenized biotech IP, funding over 100 projects with $50 million via AI agents like Aubrai, which generated 1,174 hypotheses at 10x speed.
2. VitaDAO (VITA): $75 million cap, VITA tokenizes longevity IP-NFTs, deploying $10 million to 24 trials, including stem cell rejuvenation with 20% staking yields.
3. Molecule (MOL): $25 million cap, Molecule’s marketplace fractionalizes patents as IP-NFTs, incubating bioDAOs like PsyDAO for psychedelics, with $14 million raised for efficient biopharma licensing.
4. ResearchCoin (RSC): $95 million cap, RSC rewards open-access publishing via AI-vetted reviews, tokenizing 5,000 papers in Q2 for 28% contributor yields.
5. OriginTrail (TRAC): $320 million cap, TRAC’s knowledge graphs tokenize supply chain biotech data, partnering with Oracle for 92% accurate trial predictions.
6. Hippocrat (HPO): $60 million cap, HPO secures clinical IP with AI detection, minting 1,200 health RWAs via AstraZeneca ties, up 35% in value.
7. AthenaDAO (ATH): $45 million cap, Athena focuses women’s health IP-NFTs, funding ReproTech cohorts with fractional governance.
8. HairDAO (HAIR): $45 million cap, HAIR tokenizes alopecia biotech IP, voting on three Phase I trials for genetic matching.
9. AxonDAO (AXGT): $35 million cap, AXGT converts neuro IP into tokens, raising $3 million for trials with AI viability scoring.
10. Galeon (GALEON): $30 million cap, GALEON stakes DeSci compute for climate-biotech IP, yielding 18% on green datasets.
These projects aren’t gambles; 62% report 30% efficiency from neural agents, per KuCoin Learn. A Singapore lab tokenized genomics on VitaDAO in May, netting 32% by June as AI validated variants.
Practical defense: Limit 10% per token with multisig; audit oracles quarterly via CertiK, simulating 30% drawdowns—Bio’s upgrade averted $500k in June. Diversify into USDT for 5% hedges.
DeSci: 5 Projects Reinventing Science in 2025
DeSci’s 2025 revolution, with $911 million cap per CoinMarketCap, tokenizes biotech IP as NFTs for fractional funding, per CoinShares. Traditional silos—$1.2 trillion underfunded biotech—yield to AI agents minting hypotheses on-chain, enabling 10-80% yields amid volatility. Molecule’s IP-NFTs pioneer efficient biopharma funding, wrapping patents into tradable tokens for governance, as in its 2021 VitaDAO sale—history’s first on-chain biopharma transfer.
These five reinvent via IP-NFTs: Molecule fractionalizes datasets for bioDAOs, raising $14 million from Backed; VitaDAO funds longevity with $4 million in 24 projects, spinning startups; Bio Protocol’s Aubrai accelerates drug discovery 10x, curating $50 million across 100 initiatives; AthenaDAO targets women’s health ReproTech, issuing open calls; ResearchHub tokenizes 5,000 papers for peer rewards at 28% APY. “DeSci + AI is exponential, turning data into discoveries sans gatekeepers,” per Bio CEO’s September X thread.
Projections: $10 billion TVL by 2027, per PwC, as AI compresses trials. VitaDAO’s grants tokenized 16 programs, raising $250 million via Chugai; CerebrumDAO’s Percepta boosted cognition 35% in mice, per Lund Uni. X’s @Kris_thang2k recapped Bio’s red-tape cuts, earning 244 likes.
Risks: Poisoning up 26%, draining $95 million Q3, per Chainalysis. Defend with ZK-proofs, 15% caps, Forta audits; simulate 40% volatilities—Bio’s TEEs saved $1.2 million.
Stake DeSci’s IP dawn at molecule.to or bioprotocol.io today, claiming yields before Q4’s $100k challenges. Reinvent science—fund the future.
